ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $21,547,000 | -32.3% | 533,096 | -3.7% | 0.01% | -25.0% |
| Q2 2015 | $31,837,000 | -56.8% | 553,328 | -52.2% | 0.01% | -14.3% |
| Q1 2015 | $73,694,000 | +100.0% | 1,157,410 | +94.0% | 0.01% | 0.0% |
| Q4 2014 | $36,842,000 | +71.4% | 596,730 | +7.8% | 0.01% | +55.6% |
| Q3 2014 | $21,494,000 | +14.6% | 553,537 | +1.7% | 0.01% | +12.5% |
| Q2 2014 | $18,761,000 | -31.9% | 544,551 | -14.6% | 0.01% | -33.3% |
| Q1 2014 | $27,563,000 | -10.7% | 637,862 | -17.6% | 0.01% | -7.7% |
| Q4 2013 | $30,852,000 | +5.1% | 774,400 | -1.0% | 0.01% | -7.1% |
| Q3 2013 | $29,361,000 | -10.2% | 782,140 | -35.7% | 0.01% | -17.6% |
| Q2 2013 | $32,702,000 | – | 1,217,045 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |